Pfizer Inc.
Organization details
- Legal name
- Pfizer Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PFE
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000078003
- EIN
- 13-5315170
- Wikidata ID
- Q206921
Board of directors
-
Albert Bourla · Director · Chairman & CEOSince 2023
-
Cyrus Taraporevala · DirectorSince 2024
-
Dan R. Littman · DirectorSince 2023
-
Helen Hobbs · DirectorSince 2023
-
James C. Smith · DirectorSince 2023
-
James Quincey · DirectorSince 2023
-
Johnson Suzanne M. Nora · DirectorSince 2023
-
Joseph Echevarria · DirectorSince 2023
-
Mortimer J. Buckley · DirectorSince 2024
-
Ronald E. Blaylock · DirectorSince 2023
-
Scott Gottlieb · DirectorSince 2023
-
Shantanu Narayen · DirectorSince 2023
-
Susan Desmond-Hellmann · DirectorSince 2023
-
Susan Hockfield · DirectorSince 2023
Chief executives
Mixed · grade D
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 50% of the scoring weight is on file.
- Dividends 15%
- 61
- Revenue growth 20%
- 68
- Earnings growth 15%
- 31
dividend grew 3.2% a year
6.3% a year in revenue
-4.5% a year in earnings per share
50% of the scoring weight is on file. Figures cover December 2018 – December 2025.
Director election results
Annual meeting of April 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.7%
-
92.3%
-
92.6%
-
93.5%
-
95.4%
-
96.0%
-
96.0%
-
96.3%
-
97.1%
-
97.4%
-
97.8%
Board connections
7 of this board's directors also sit on 12 other boards.
- via Shantanu Narayen
- via Ronald E. Blaylock
- via Scott Gottlieb
- via Johnson Suzanne M. Nora
- via Johnson Suzanne M. Nora
- via Scott Gottlieb
- via Joseph Echevarria
- via Mortimer J. Buckley
- via James Quincey
- via Scott Gottlieb
- via Joseph Echevarria
- via Ronald E. Blaylock
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,960,110
- 3 purchases by 3 insiders
- Sold, last 12 months
- $134,661
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | Albert Bourla Director, Officer (Chairman & CEO) | Open-market purchase | +38,000 | $26.34 | $1,000,920 |
| Aug 5, 2026 | Ronald E. Blaylock Director | Open-market purchase | +39,231 | $25.46 | $998,821 |
| Aug 5, 2026 | Mortimer J. Buckley Director | Open-market purchase | +37,632 | $25.52 | $960,369 |
| Aug 5, 2026 | DAMICO JENNIFER B. Officer (SVP & Controller) | Open-market sale | −3,278 | $25.40 | $83,261 |
| Jun 9, 2026 | DAMICO JENNIFER B. Officer (SVP & Controller) | Open-market sale | −2,000 | $25.70 | $51,400 |
| Mar 4, 2026 | DAMICO JENNIFER B. Officer (SVP & Controller) | Shares withheld for tax | −826 | $26.62 | $21,988 |
| Mar 3, 2026 | DAMICO JENNIFER B. Officer (SVP & Controller) | Grant or award | +16,311 | — | — |
| Mar 3, 2026 | DAMICO JENNIFER B. Officer (SVP & Controller) | Grant or award | +5,408 | — | — |
| Feb 27, 2026 | DAMICO JENNIFER B. Officer (SVP & Controller) | Shares withheld for tax | −655 | $27.65 | $18,111 |
| Feb 26, 2026 | McDermott Michael Officer (Executive Vice President) | Shares withheld for tax | −3,503 | $27.10 | $94,931 |
| Feb 25, 2026 | SAHNI PAYAL Officer (Executive Vice President) | Option exercise | +56,888 | $33.82 | $1,923,952 |
| Feb 25, 2026 | LANKLER DOUGLAS M Officer (Executive Vice President) | Option exercise | +122,907 | $33.82 | $4,156,715 |
| Feb 25, 2026 | DAMICO JENNIFER B. Officer (SVP & Controller) | Option exercise | +17,558 | $33.82 | $593,812 |
| Feb 25, 2026 | Albert Bourla Director, Officer (Chairman & CEO) | Option exercise | +491,626 | $33.82 | $16,626,791 |
| Feb 25, 2026 | Lidia Fonseca Officer (Executive Vice President) | Option exercise | +56,888 | $33.82 | $1,923,952 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Pfizer Inc.
Who is the CEO of Pfizer Inc.?
Albert Bourla has been Pfizer Inc.'s Chairman & CEO since January 2019.
How many directors are on Pfizer Inc.'s board?
Pfizer Inc.'s board has 14 directors: Albert Bourla, Cyrus Taraporevala, Dan R. Littman, Helen Hobbs, James C. Smith, James Quincey, Johnson Suzanne M. Nora, Joseph Echevarria, Mortimer J. Buckley, Ronald E. Blaylock and 4 others.
Are Pfizer Inc. insiders buying or selling shares?
Over the last 12 months, Pfizer Inc. insiders bought $3.0 million of shares in 3 purchases and sold $134,661 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="pfizer-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.